KARD

Kardigan, Inc.

Healthcare · Biotechnology

14.10$ -9.9% vs. previous close Closing price · As of: Nov 12, 2026

Statements

Income Statement

Kardigan, Inc. (KARD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement KARD
Line item	2024	2025
Revenue	0.0	0.0
Research & Development	84	153
Selling, General & Administrative	12	49
Total Operating Expenses	97	202
Operating Income	-97	-202
Pre-Tax Income	-89	-196
Income Tax Expense	–	-4.5
Net Income	-89	-192
EBITDA	-96	-196

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Income Statement

Cookie settings